| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Cardiol Therapeutics Inc.
13G/A
CRDL · 14161Y200
|
5.3% |
9/23/2026
Event 9/2/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.